Eri Sugiyama
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.
Journal: Cancer immunology research
Published: June 04, 2025
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-related Haplotypes.
Journal: Cancer immunology research
Published: June 04, 2025
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 13, 2025
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 11, 2024
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: May 03, 2024
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: April 21, 2024
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 21, 2023
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 16, 2023
Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 19, 2023
Microbiota-driven antitumour immunity mediated by dendritic cell migration.
Journal: Nature
Published: January 16, 2023
Last Updated: 09/26/2026